Previous studies have shown alterations in the levels and affinity of nAbs against αSyn, Aβ, and tau in these diseases, suggesting that dysfunction in the immune clearance of pathological proteins may play an considerable role in the development of neurodegenerative diseases [12, 13]. This evidence concerns the gene MAPT and neurodegenerative disease.